Literature DB >> 2567639

Enhancement of hepatocarcinogenesis in rats by dietary fructose.

H Enzmann1, D Ohlhauser, T Dettler, P Bannasch.   

Abstract

The effects of oral fructose on hepatocarcinogenesis were investigated with cytomorphological, cytochemical and stereological methods. Carcinogenesis was induced in male Sprague-Dawley rats by application of N-nitrosomorpholine (NNM) for 7 weeks. Afterwards, the animals received fructose in the drinking water (120 g/l) and food ad libitum (group I) or tap water and food ad libitum (group II). The incidence of hepatocellular carcinoma in rats treated with NNM plus fructose was 46% as compared to 24% in animals receiving NNM alone (P less than 0.05). There was no difference in the incidences of other malignancies between the groups (group I: 32.1%, group II: 32.0%). Morphometric evaluation of preneoplastic liver lesions indicated the enhancing effect of the fructose treatment several months before malignant tumors appeared. As early as 6 weeks after treatment the hepatic parenchyma occupied by focal lesions was increased from 6.7% in the animals which had received NNM alone to 8.5% (P less than 0.05) in animals having received NNM plus fructose. This increase was predominantly caused by an increase in glycogen storing foci (P less than 0.0005). In addition, the fructose treatment caused a histochemically detectable increase in the activity of glucose-6-phosphatase and glucose-6-phosphate dehydrogenase in both the hepatocytes of the focal lesions and the surrounding parenchyma. In the NNM plus fructose group the activity of the glucose-6-phosphatase in the foci was frequently approximately equal to the activity in the parenchyma of untreated controls. The striking increase in the activity of this enzyme in the surrounding hepatocytes, however, still sharply demarcated the lesions. The potential mechanisms by which fructose enhances hepatocarcinogenesis are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567639     DOI: 10.1093/carcin/10.7.1247

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  8 in total

1.  Effects of sorafenib and cisplatin on preneoplastic foci of altered hepatocytes in fetal turkey liver.

Authors:  Bettina Kaestner; Karsten Spicher; Ulrich Jaehde; Harald Enzmann
Journal:  Toxicol Res (Camb)       Date:  2016-11-02       Impact factor: 3.524

2.  Fructose as a carbon source induces an aggressive phenotype in MDA-MB-468 breast tumor cells.

Authors:  Behjatolah Monzavi-Karbassi; R Jean Hine; Joseph S Stanley; Vishnu Prakash Ramani; Jaime Carcel-Trullols; Tracy L Whitehead; Thomas Kelly; Eric R Siegel; Cecile Artaud; Saeid Shaaf; Rinku Saha; Fariba Jousheghany; Ronda Henry-Tillman; Thomas Kieber-Emmons
Journal:  Int J Oncol       Date:  2010-09       Impact factor: 5.650

Review 3.  Simple sugar intake and hepatocellular carcinoma: epidemiological and mechanistic insight.

Authors:  Juan Carlos Laguna; Marta Alegret; Núria Roglans
Journal:  Nutrients       Date:  2014-12-22       Impact factor: 5.717

4.  Dietary sugar intake increases liver tumor incidence in female mice.

Authors:  Marin E Healy; Sujoy Lahiri; Stefan R Hargett; Jenny D Y Chow; Frances L Byrne; David S Breen; Brandon M Kenwood; Evan P Taddeo; Carolin Lackner; Stephen H Caldwell; Kyle L Hoehn
Journal:  Sci Rep       Date:  2016-02-29       Impact factor: 4.379

5.  Insulin-tumour interrelationships in thymoma bearing mice. Effects of dietary glucose and fructose.

Authors:  D Yam; A Fink; I Nir; P Budowski
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

6.  Consumption of sweet foods and mammographic breast density: a cross-sectional study.

Authors:  Caroline S Duchaine; Isabelle Dumas; Caroline Diorio
Journal:  BMC Public Health       Date:  2014-06-26       Impact factor: 3.295

7.  Dietary fructose enhances the incidence of precancerous hepatocytes induced by administration of diethylnitrosamine in rat.

Authors:  Ryo Kumamoto; Hirofumi Uto; Kohei Oda; Rie Ibusuki; Shirou Tanoue; Shiho Arima; Seiichi Mawatari; Kotaro Kumagai; Masatsugu Numata; Tsutomu Tamai; Akihiro Moriuchi; Hiroshi Fujita; Makoto Oketani; Akio Ido; Hirohito Tsubouchi
Journal:  Eur J Med Res       Date:  2013-12-09       Impact factor: 2.175

8.  Aldose reductase interacts with AKT1 to augment hepatic AKT/mTOR signaling and promote hepatocarcinogenesis.

Authors:  Jia-Xing Zhao; Ya-Wei Yuan; Cheng-Fu Cai; Dong-Yan Shen; Mao-Li Chen; Feng Ye; Yan-Jun Mi; Qi-Cong Luo; Wang-Yu Cai; Wei Zhang; Ying Long; Yong Zeng; Guo-Dong Ye; Shu-Yu Yang
Journal:  Oncotarget       Date:  2017-05-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.